2019 Early Confirmed Speakers

Jeff Myers , CEO, Medicaid Health Plans of America

Luc Boileau , Président-directeur general, INESSS

Carla Deakin , Associate Director – Accelerated Access Collaborative Secretariat & NICE Office for Market Access, NICE

Bart Vermeulen , Deputy Director Healthcare at Office of the Minister of Social Affairs and Public Health, Belgian Federal Government 

Charles-Etienne de Cidrac , Director Health, AXA

Wim Goettsch , Special HTA-advisor, Dutch National Health Care Institute (Zorginstituut Nederland)

Giuseppe Rosano , Member of the Cardiovascular Working Party, EMA

Malcolm Qualie , Pharmacy Lead, Specialised Commissioning, NHS England

Sheela Upadhyaya , Associate Director Highly Specialised Technologies, Centre for Health Technology Evaluation, NICE

Carlos Sanchez Pavón , EMEA Regional Director, Promexico

Detlev Parow , Head of Department of Medicines, Therapeutic Appliances and Remedies, DAK-Gesundheit

Diar Fattah , Associate Director of Medicines Optimisation, NHS Dartford, Gravesham and Swanley CCG

Tanya Potashnik , Director, Policy and Economics Analysis Branch, Analysis Branch, Patented Medicine Prices Review Board, Government of Canada

Nneka Onwudiwe , PRO/PE Scientific Reviewer, FDA

Edmund Pezalla , Former VP Pharmaceutical Policy and Strategy, Aetna

Antje Behring , Team Leader and Senior Scientific Advisor, G-BA

Steinar Madsen , Medical Director, Norwegian Medicines Agency

Martin Van Der Graaff , Secretary Scientific Advisory Board (WAR), National Health Care Institute (Zorginstituut Nederland)

Rob Scott , Chief Medical Officer and VP Development, AbbVie

Isabel Torres , Vice President Market Access, Public Affairs and Patient Advocacy for Europe and Canada, Takeda

Navin Joshi , Head of Pricing & Access Capabilities, Emerging Markets & Asia Pacific, GSK

Ben Gannon , Senior Director of Global Government Affairs and Policy, Vertex Pharmaceuticals

Ana Plata , Global Head, Access Strategy for New Medicines, UCB

Andrew Richards , Senior Director, Head of Global Market Access & Pricing, Ferring International 

David Pritchard , VP & Area Head Africa and Developing Countries, GSK

Igor Rudychev , Sr. Director, Business Insights, Immuno-Oncology, AstraZeneca 

Adam Plich , Vice President, Head of Pricing & Market Access Europe, Teva Pharmaceuticals

Dan Pettitt , Global Head, Immunology Market Access (Health Economics and Reimbursement) & Policy, Johnson & Johnson

Mig Sleeper , VP, Head of Global Market Access & Pricing, Astellas Pharmaceuticals

Simon Shohet , Senior Director, Global Market Access and Pricing, Ipsen

Steven Flostrand , Senior Director, Pricing & Market Access, Celgene

Darren Walsh , Senior Director - Market Access & Govt. Affairs – EU, Orchard Therapeutics

Farzana Malik , Vice President Market Access, Vicarius Pharmaceuticals

Marco Rauland , Global Head Pricing & Payer Excellence, Merck

Francis Pang , VP and Head, Global Market Access, Amicus Theraputics

Siva Narayanan , Vice President and Global Head, Market Access, PTC Therapeutics

Chris Hill , Head of Strategic Pricing UK & Ireland, Sanofi

Paul Robinson , Executive Director, Scientific Medical & Patient Perspective, MSD

Keiko Tone , VP, Global Market Access, Shionogi Limited

Victor Lino Mendonça , Head of Policy & Market Access – Europe, Mylan

Erik Smets , Vice President, Head of Patient Experience and Value, UCB

Reg Waldeck , Market Access Strategy Leader, Bayer

Gundula Schneidewind , Managing Director, Takeda Belgium

Diego Ardigò , R&D Rare Diseases Unit Head, Chiesi Group

Melvin Olson , Global Head of HEOR, Novartis

Sue Naeyaert , Global Head Government Affairs and Policy Biosimilars, Fresenius Kabi

Sachin Kamal-Bahl , Vice President & Head, Global Health & Value Innovation Center, Pfizer

Clive Whitcher , Vice President of Global Pricing and Patient Access, Sobi

Paul Newton , Director Strategic Pricing & Market Access EMEA Canada, UCB

Nicola Redfern , Director, Access Value and Evidence Strategy UK, bluebird bio 

Anastasiya Stepanova , Government Affairs Manager, STADA

Sophie Beucher , Global Value & Access Lead, Sanofi 

Marco Penske , Head Market Access & Healthcare Affairs, Boehringer Ingelheim

William Dunlop , Head of Market Access, Mundi pharma International

Adam Heathfield , Senior Director, Global Health and Value Innovation Centre, Pfizer

Etienne Jousseaume , Head Market Access, Cell & Gene Therapies Europe, Novartis

Natalya Danchenko , Global Market Access and Pricing Director, Ipsen

Michael Schroter , Head of Personalised Reimbursment Models, Global Pricing and Market Access, Roche

Diann Potestio , Senior Director, National Accounts, Multiple Sclerosis & Immunology, Sanofi Genzyme

John Alter , VP Global Health & Value, Global Established Pharma Business Unit, Pfizer

Martin Whitehead , Associate Director of Market Access UK and Ireland, Jazz Pharmaceuticals

Adrian Griffin , VP, HTA Policy, Johnson & Johnson

Jenny Hughes , Head, Market Access Capabilities, GSK

Daria Tolkacheva , Head of Health Economics, BIOCAD

Fabrizio Zucca , Director Patient Access Central Europe, SOBI

Cristina Martin-Rinconada , Associate Director Strategic Pricing, Biosimilars, Biogen

Omar Dabbous , Vice President of Global HEOR and RWE, Avexis

Sébastien Le Roux , VP, Global Market Access & Healthcare Solutions, GSK

Michael Lees , Head of Value, Evidence & Portfolio Strategy (EUCAN), Takeda

Axel Boehnke , Director Market Access & Reimbursement D-A-CH, Morphosys

Nadeem Ashraf , Medical Advisor – Diabetes, Lilly

David Boothe , Regional Commercial Head, Spark Therapeutics

Deven Chauhan , Senior Director, Value Evidence Leader, Immuno-inflammation, Value Evidence & Outcomes (VEO), GSK

Mike Crosher , Value and Access Director, Chugai Pharma

Karen Hockey , Director, Global Market Access & Government Affairs, Norgine

Gordon Lundie , Director of Market Access, Gilead Sciences 

Davide Finocchiaro , Global Pricing & Market Access Specialist, Chiesi

Dimitrios Tsourougiannis , Associate Director, EMEA Health Economics & Outcomes Research, Astellas Pharma Europe

Jolanda Koenders , Head of Pricing and Market Access, Novartis

Dawn Ireland , President, CDH international

Gerard Slevin , National Hospitals Manager, STADA

Richard Stephens , Consumer Lead, Chair Consumer Forum, National Cancer Research Institute

Friedhelm Leverkus , Director Health Technology Assessment & Outcomes Research, Health & Value, Pfizer

David Williams , Global Engagement Lead Real World Data- General Medicine and Emerging markets and Consumer Health, Sanofi

Enkeleida Nikai , Director, Real World Evidence, Global Patient Outcomes and Real World Evidence (GPORWE) International, Eli Lilly

Elena Panitti , Global RWE Capability Building Lead, Novartis

Marcela Junqueira , Head of Value Demonstration and Access, Shire Farmacêutica Brasil Ltda

Alan Hochberg , Scientific Enablement Leader, Roche 

James Kavanagh , HEOR and Strategic Pricing Manager, Abbvie

Matteo Ferrario , Value Strategy Manager, Roche

Jenny Ebert , Regional Account Director, Sanofi Genzyme  

Jose Diaz , Group Director - Intercontinental Region & Japan-Korea-Taiwan Cluster WWHEOR Markets, Bristol Myers Squibb

José Luis Sánchez Chorro , Head of Market Access, Shire  

Jorg Mahlich , Director Health Economics, Janssen Pharmaceutical K.K

Andrea Mantovani , Value and Access Director, Amgen 

Mohamed Hamada , Country Portfolio Lead, Women’s Health – Egypt & Sudan, Pfizer

Thomas Abbott , Global Head, Real World Informatics Capabilities and Alliances, Astellas

Hassan Bruneo , Associate Director, Alnylam

Laura Cockram , Head of Policy and Campaigns, Parkinson's UK

Derick Mitchell , Chief Executive, IPPOSI

Maarten Van Baelen , Market Access Director, Medicines for Europe 

Robert Orzechowski , Chief Operating Officer, Lancaster Cancer Center

David Watson , Director Pricing and Reimbursement, ABPI

Anna Bucsics , Project Advisor, MoCA

Francis Crawley , Executive Director, Good Clinical Practice Alliance – Europe (GCPA)

Alexander Natz , Secretary General, European Confederation of Pharmaceutical Entrepreneurs

Shameer Khader , Program Director (Healthcare Data Science and Bioinformatics), Northwell Health

Anne Marciniak , Affiliate, Brunel University, London